๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Characterization of antigenic peptide epitopes by reverse immunology: Induction of cytotoxic T lymphocytes specific for exogenous peptide only

โœ Scribed by Silvia Tanzarella; Katharina Fleischhauer; Peter van Endert; Claudio Bordignon; Catia Traversari


Publisher
John Wiley and Sons
Year
1997
Tongue
French
Weight
59 KB
Volume
72
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Identification of HER2/neu-derived pepti
โœ Koji Kono; Yang Rongcun; Jehad Charo; Fumiko Ichihara; Esteban Celis; Alessandro ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 127 KB ๐Ÿ‘ 1 views

We have derived HLA-A2.1-restricted, gastric cancerspecific cytotoxic T lymphocyte (CTL) lines by repetitive in vitro stimulation of tumor-associated lymphocytes (TAL) with autologous tumor cells. The HER2/neu specificity of these gastric cancer-specific CTLs was demonstrated using HER2/neu-transfec

Induction of prostate tumor-specific CD8
โœ Peshwa, Madhusudan V.; Shi, Jia Dong; Ruegg, Curtis; Laus, Reiner; van Schooten, ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 195 KB ๐Ÿ‘ 2 views

## BACKGROUND. Most strategies in cancer immunotherapy are aimed at the induction of a strong cellular immune response against the tumor. Particularly, CD8 + T lymphocytes have been proven in multiple animal models to be critical for the eradication of solid tumors. METHODS. We used a population o

Identification of GP100-derived, melanom
โœ Ichiro Kawashima; Van Tsai; Scott Southwood; Kazutoh Takesako; Esteban Celis; Al ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 118 KB ๐Ÿ‘ 2 views

The human melanocyte lineage-specific antigen gp100 contains several epitopes recognized by cytotoxic T lymphocytes (CTL). However, most of the epitopes reported to date are HLA-A2.1-restricted. Despite the high frequency of HLA-A2.1 in melanoma patients, effective population coverage requires the i

Induction of carcinoembryonic antigen (c
โœ Smita K. Nair; Shelley Hull; Doris Coleman; Eli Gilboa; H. Kim Lyerly; Michael A ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 107 KB ๐Ÿ‘ 2 views

The application of dendritic cells (DC) to the active immunotherapy of cancer currently relies on the generation of potent DC capable of presenting tumor antigens such as carcinoembryonic antigen (CEA). It is unknown whether the T cells of patients with advanced malignancies can be reliably stimulat